Global Bispecific Antibody Therapeutic Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Bispecific Antibody Therapeutic market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Bispecific Antibody Therapeutic market.
Major Players in the Bispecific Antibody Therapeutic market are:
AbbVie
Eli Lilly
Celgene
DCPrime
AbClon
F-star
Cancer Research UK
Dana-Farber Cancer Institute
Fusion Antibodies
Fuda Cancer Hospital
GEMoaB
Calico
EMD Serono
Ab Studio
Catalent Biologics
CELLSCRIPT
Genedata
FZata
AbCellera
Bristol-Myers Squibb
FUJIFILM Diosynth Biotechnologies
On the basis of types, the Bispecific Antibody Therapeutic market is primarily split into:
Intravenous
Subcutaneous
Others
On the basis of applications, the market covers:
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Bispecific Antibody Therapeutic Market Overview
- 1.1 Product Overview and Scope of Bispecific Antibody Therapeutic Market
- 1.2 Bispecific Antibody Therapeutic Market Segment by Type
- 1.2.1 Global Bispecific Antibody Therapeutic Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Bispecific Antibody Therapeutic Market Segment by Application
- 1.3.1 Bispecific Antibody Therapeutic Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Bispecific Antibody Therapeutic Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Bispecific Antibody Therapeutic (2017-2029)
- 1.5.1 Global Bispecific Antibody Therapeutic Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Bispecific Antibody Therapeutic Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Bispecific Antibody Therapeutic Industry
- 1.7 Impact of Carbon Neutrality on the Bispecific Antibody Therapeutic Industry
- 2 Bispecific Antibody Therapeutic Market Upstream and Downstream Analysis
- 2.1 Bispecific Antibody Therapeutic Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Bispecific Antibody Therapeutic Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 AbbVie
- 3.1.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Eli Lilly
- 3.2.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Celgene
- 3.3.1 Celgene Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 DCPrime
- 3.4.1 DCPrime Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 AbClon
- 3.5.1 AbClon Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 F-star
- 3.6.1 F-star Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Cancer Research UK
- 3.7.1 Cancer Research UK Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 Dana-Farber Cancer Institute
- 3.8.1 Dana-Farber Cancer Institute Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Fusion Antibodies
- 3.9.1 Fusion Antibodies Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Fuda Cancer Hospital
- 3.10.1 Fuda Cancer Hospital Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.10.4 Business Overview
- 3.11 GEMoaB
- 3.11.1 GEMoaB Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.11.2 Product Profiles, Application and Specification
- 3.11.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.11.4 Business Overview
- 3.12 Calico
- 3.12.1 Calico Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.12.2 Product Profiles, Application and Specification
- 3.12.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.12.4 Business Overview
- 3.13 EMD Serono
- 3.13.1 EMD Serono Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.13.2 Product Profiles, Application and Specification
- 3.13.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.13.4 Business Overview
- 3.14 Ab Studio
- 3.14.1 Ab Studio Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.14.2 Product Profiles, Application and Specification
- 3.14.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.14.4 Business Overview
- 3.15 Catalent Biologics
- 3.15.1 Catalent Biologics Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.15.2 Product Profiles, Application and Specification
- 3.15.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.15.4 Business Overview
- 3.16 CELLSCRIPT
- 3.16.1 CELLSCRIPT Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.16.2 Product Profiles, Application and Specification
- 3.16.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.16.4 Business Overview
- 3.17 Genedata
- 3.17.1 Genedata Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.17.2 Product Profiles, Application and Specification
- 3.17.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.17.4 Business Overview
- 3.18 FZata
- 3.18.1 FZata Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.18.2 Product Profiles, Application and Specification
- 3.18.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.18.4 Business Overview
- 3.19 AbCellera
- 3.19.1 AbCellera Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.19.2 Product Profiles, Application and Specification
- 3.19.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.19.4 Business Overview
- 3.20 Bristol-Myers Squibb
- 3.20.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.20.2 Product Profiles, Application and Specification
- 3.20.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.20.4 Business Overview
- 3.21 FUJIFILM Diosynth Biotechnologies
- 3.21.1 FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.21.2 Product Profiles, Application and Specification
- 3.21.3 Bispecific Antibody Therapeutic Market Performance (2017-2022)
- 3.21.4 Business Overview
- 4 Global Bispecific Antibody Therapeutic Market Landscape by Player
- 4.1 Global Bispecific Antibody Therapeutic Sales and Share by Player (2017-2022)
- 4.2 Global Bispecific Antibody Therapeutic Revenue and Market Share by Player (2017-2022)
- 4.3 Global Bispecific Antibody Therapeutic Average Price by Player (2017-2022)
- 4.4 Global Bispecific Antibody Therapeutic Gross Margin by Player (2017-2022)
- 4.5 Bispecific Antibody Therapeutic Market Competitive Situation and Trends
- 4.5.1 Bispecific Antibody Therapeutic Market Concentration Rate
- 4.5.2 Bispecific Antibody Therapeutic Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Bispecific Antibody Therapeutic Sales, Revenue, Price Trend by Type
- 5.1 Global Bispecific Antibody Therapeutic Sales and Market Share by Type (2017-2022)
- 5.2 Global Bispecific Antibody Therapeutic Revenue and Market Share by Type (2017-2022)
- 5.3 Global Bispecific Antibody Therapeutic Price by Type (2017-2022)
- 5.4 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate of Intravenous (2017-2022)
- 5.4.2 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate of Subcutaneous (2017-2022)
- 5.4.3 Global Bispecific Antibody Therapeutic Sales, Revenue and Growth Rate of Others (2017-2022)
- 6 Global Bispecific Antibody Therapeutic Market Analysis by Application
- 6.1 Global Bispecific Antibody Therapeutic Consumption and Market Share by Application (2017-2022)
- 6.2 Global Bispecific Antibody Therapeutic Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Bispecific Antibody Therapeutic Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Bispecific Antibody Therapeutic Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
- 6.3.2 Global Bispecific Antibody Therapeutic Consumption and Growth Rate of Online Pharmacy (2017-2022)
- 6.3.3 Global Bispecific Antibody Therapeutic Consumption and Growth Rate of Retail Pharmacy (2017-2022)
- 7 Global Bispecific Antibody Therapeutic Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Bispecific Antibody Therapeutic Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Bispecific Antibody Therapeutic Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Bispecific Antibody Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Bispecific Antibody Therapeutic Market Forecast (2022-2029)
- 8.1 Global Bispecific Antibody Therapeutic Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Bispecific Antibody Therapeutic Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Bispecific Antibody Therapeutic Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Bispecific Antibody Therapeutic Price and Trend Forecast (2022-2029)
- 8.2 Global Bispecific Antibody Therapeutic Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Bispecific Antibody Therapeutic Sales and Revenue Forecast (2022-2029)
- 8.3 Global Bispecific Antibody Therapeutic Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Bispecific Antibody Therapeutic Revenue and Growth Rate of Intravenous (2022-2029)
- 8.3.2 Global Bispecific Antibody Therapeutic Revenue and Growth Rate of Subcutaneous (2022-2029)
- 8.3.3 Global Bispecific Antibody Therapeutic Revenue and Growth Rate of Others (2022-2029)
- 8.4 Global Bispecific Antibody Therapeutic Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Bispecific Antibody Therapeutic Consumption Value and Growth Rate of Hospital Pharmacy (2022-2029)
- 8.4.2 Global Bispecific Antibody Therapeutic Consumption Value and Growth Rate of Online Pharmacy (2022-2029)
- 8.4.3 Global Bispecific Antibody Therapeutic Consumption Value and Growth Rate of Retail Pharmacy (2022-2029)
- 8.5 Bispecific Antibody Therapeutic Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Bispecific Antibody Therapeutic Market Drivers Analysis
- 9.2 Bispecific Antibody Therapeutic Market Restraints and Challenges
- 9.3 Bispecific Antibody Therapeutic Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Bispecific Antibody Therapeutic Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Bispecific Antibody Therapeutic Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Bispecific Antibody Therapeutic Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
- 1.2 Bispecific Antibody Therapeutic Market Segment by Type
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook